Peptides involved in vascular homeostasis

Peptides in Energy Balance and Obesity: Frontiers in Nutritional Science

Volumn , Issue , 2009, Pages 229-261

  Rodríguez, Amaia ^a   Frühbeck, Gema ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954554765     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (210)

1. Adya, R., Tan, B.K., Punn, A., Chen, J. and Randeva, H.S. (2008) Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovascular Research 78, 356-365.
2. Agata, J., Masuda, A., Takada, M., Higashiura, K., Murakami, H., Miyazaki, Y. and Shimamoto, K. (1997) High plasma immunoreactive leptin level in essential hypertension. The American Journal of Hypertension 10, 1171-1174.
3. Ahima, R. (2006) Ghrelin -a new player in glucose homeostasis?. Cell Metabolism 3, 301-302.
4. Ahren, B., Havel, P., Pacini, G. and Cianflone, K. (2003) Acylation stimulating protein stimulates insulin secretion. International Journal of Obesity and Related Metabolic Disorders 27, 1037-1043.
5. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T. and Matsuzawa, Y. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 257, 79-83.
6. Aronson, D., Bartha, P., Zinder, O., Kerner, A., Markiewicz, W., Avizohar, O., Brook, G.J. and Levy, Y. (2004) Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. International Journal of Obesity and Related Metabolic Disorders 28, 674-679.
7. Azuma, K., Katsukawa, F., Oguchi, S., Murata, M., Yamazaki, H., Shimada, A. and Saruta, T. (2003) Correlation between serum resistin level and adiposity in obese individuals. Obesity Research 11, 997-1001.
8. Baldanzi, G., Filigheddu, N., Cutrupi, S., Catapano, F., Bonissoni, S., Fubini, A., Malan, D., Baj, G., Granata, R., Broglio, F., Papotti, M., Surico, N., Bussolino, F., Isgaard, J., Deghenghi, R., Sinigaglia, F., Prat, M., Muccioli, G., Ghigo, E. and Graziani, A. (2002) Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. The Journal of Cell Biology 159, 1029-1037.
9. Beltowski, J., Wojcicka, G. and Jamroz-Wisniewska, A. (2006) Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats. Life Sciences 79, 63-71.
10. Berg, A.H. and Scherer, P.E. (2005) Adipose tissue, inflammation, and cardiovascular disease. Circulation Research 96, 939-949.
11. Bodary, P. and Eitzman, D. (2006) Adiponectin: vascular protection from the fat?. Arteriosclerosis, Thrombosis, and Vascular Biology 26, 235-236.
12. Boucher, J., Masri, B., Daviaud, D., Gesta, S., Guigne, C., Mazzucotelli, A., Castan-Laurell, I., Tack, I., Knibiehler, B., Carpene, C., Audigier, Y., Saulnier-Blache, J. and Valet, P. (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146, 1764-1771.
13. Bouloumié, A., Drexler, H.C., Lafontan, M. and Busse, R. (1998) Leptin, the product of Ob gene, promotes angiogenesis. Circulation Research 83, 1059-1066.
14. Broch, M., Vendrell, J., Ricart, W., Richart, C. and Fernández-Real, J.M. (2007) Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and non-obese subjects. Diabetes Care 30, 1802-1806.
15. Burstein, S., Peng, J., Friese, P., Wolf, R., Harrison, P., Downs, T., Hamilton, K., Comp, P. and Dale, G. (1996) Cytokine-induced alteration of platelet and hemostatic function. Stem Cells 14 (Suppl. 1), 154-162.
16. Caro, J., Sinha, M., Kolaczynski, J., Zhang, P. and Considine, R. (1996) Leptin: the tale of an obesity gene. Diabetes 45, 1455-1462.
17. Chen, M., Tsai, J., Chung, F., Yang, S., Hsing, L., Shin, S. and Lee, Y. (2005) Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 25, 821-826.
18. Chen, M.P., Chung, F.M., Chang, D.M., Tsai, J.C., Huang, H.F., Shin, S.J. and Lee, Y.J. (2006) Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 91, 295-299.
19. Cheng, X., Cheng, X.S. and Pang, C.C. (2003) Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. The European Journal of Pharmacology 470, 171-175.
20. Cianflone, K.M., Sniderman, A.D., Walsh, M.J., Vu, H.T., Gagnon, J. and Rodríguez, M.A. (1989) Purification and characterization of acylation stimulating protein. Journal of Biological Chemistry 264, 426-430.
21. Cianflone, K., Zhang, X., Genest, J.J. and Sniderman, A. (1997) Plasma acylation-stimulating protein in coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 17, 1239-1244.
22. Cianflone, K., Xia, Z. and Chen, L. (2003) Critical review of acylation-stimulating protein physiology in humans and rodents. Biochimica et Biophysica Acta 1609, 127-143.
23. Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R., Ohannesian, J.P., Marco, C.C., McKee, L.J., Bauer, T.L. and Caro, J.F. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine 334, 292-295.
24. Crandall, D., Herzlinger, H., Saunders, B., Armellino, D. and Kral, J. (1994) Distribution of angiotensin II receptors in rat and human adipocytes. Journal of Lipid Research 35, 1378-1385.
25. Davi, G., Guagnano, M., Ciabattoni, G., Basili, S., Falco, A., Marinopiccoli, M., Nutini, M., Sensi, S. and Patrono, C. (2002) Platelet activation in obese women: role of inflammation and oxidant stress. The Journal of the American Medical Association 288, 2008-2014.
26. Degawa-Yamauchi, M., Bovenkerk, J., Juliar, B., Watson, W., Kerr, K., Jones, R., Zhu, Q. and Considine, R. (2003) Serum resistin (FIZZ3) protein is increased in obese humans. Journal of Clinical Endocrinology and Metabolism 88, 5452-5455.
27. Delanghe, J.R., Langlois, M.R., De Bacquer, D., Mak, R., Capel, P., Van Renterghem, L. and De Backer, G. (2002) Discriminative value of serum amyloid A and other acutephase proteins for coronary heart disease. Atherosclerosis 160, 471-476.
28. De Taeye, B., Smith, L.H. and Vaughan, D.E. (2005) Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. Current Opinion in Pharmacology 5, 149-154.
29. Dick, G.M., Katz, P.S., Farias, M. 3rd, Morris, M., James, J., Knudson, J.D. and Tune, J.D. (2006) Resistin impairs endothelium-dependent dilation to bradykinin, but not acetylcholine, in the coronary circulation. American Journal of Physiology -Heart and Circulatory Physiology 291, H2997-3002.
30. Dogru, T., Sonmez, A., Tasci, I., Bozoglu, E., Yilmaz, M.I., Genc, H., Erdem, G., Gok, M., Bingol, N., Kilic, S., Ozgurtas, T. and Bingol, S. (2007) Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Research and Clinical Practice 76, 24-29.
31. Eckel, R.H. and Krauss, R.M. (1998) American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 97, 2099-2100.
32. Eckel, R.H., Grundy, S.M. and Zimmet, P.Z. (2005) The metabolic syndrome. Lancet 365, 1415-1428.
33. Engeli, S., Bohnke, J., Gorzelniak, K., Janke, J., Schling, P., Bader, M., Luft, F. and Sharma, A. (2005) Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45, 356-362.
34. Esler, M. (2000) The sympathetic system and hypertension. American Journal of Hypertension 13, 99S-105S.
35. Esmon, C. (2004) The impact of the inflammatory response on coagulation. Thrombosis Research 114, 321-327.
36. Fain, J., Madan, A., Hiler, M., Cheema, P. and Bahouth, S. (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273-2282.
37. Flórez, H., Castillo-Flórez, S., Méndez, A., Casanova-Romero, P., Larreal-Urdaneta, C., Lee, D. and Goldberg, R. (2006) C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Research and Clinical Practice 71, 92-100.
38. Földes, G., Horkay, F., Szokodi, I., Vuolteenaho, O., Ilves, M., Lindstedt, K.A., Mäyränpää, M., Sarman, B., Seres, L., Skoumal, R., Lako-Futo, Z., deChatel, R., Ruskoaho, H. and Toth, M. (2003) Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochemical and Biophysical Research Communications 308, 480-485.
39. Fortuño, A., Rodríguez, A., Gómez-Ambrosi, J., Muñiz, P., Salvador, J., Díez, J. and Frühbeck, G. (2002) Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in rat aorta. Endocrinology 143, 3555-3560.
40. Franks, P., Brage, S., Luan, J., Ekelund, U., Rahman, M., Farooqi, I., Halsall, I., O'Rahilly, S. and Wareham, N. (2005) Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obesity Research 13, 1476-1484.
41. Frühbeck, G. (1999) Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 48, 903-908.
42. Frühbeck, G. (2004) The adipose tissue as a source of vasoactive factors. Current Medicinal Chemistry -Cardiovascular and Hematological Agents 2, 197-208.
43. Frühbeck, G., Gómez-Ambrosi, J., Muruzábal, F.J. and Burrell, M.A. (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. American Journal of Physiology -Endocrinology and Metabolism 280, E827-847.
44. Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., Watanabe, E., Takagi, T., Akiyoshi, M., Ohtsubo, T., Kihara, S., Yamashita, S., Makishima, M., Funahashi, T., Yamanaka, S., Hiramatsu, R., Matsuzawa, Y. and Shimomura, I. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426-430.
45. Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., Watanabe, E., Takagi, T., Akiyoshi, M., Ohtsubo, T., Kihara, S., Yamashita, S., Makishima, M., Funahashi, T., Yamanaka, S., Hiramatsu, R., Matsuzawa, Y. and Shimomura, I. (2007) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Retraction. Science 318, 565.
46. Gálvez, B., Castro, J. de, Herold, D., Dubrovska, G., Arribas, S., González, M.C., Aránguez, I., Luft, F.C., Ramos, M.P., Gollasch, M. and Fernández Alfonso, M.S. (2006) Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive rats. Arteriosclerosis, Thrombosis, and Vascular Biology 26, 1297-1302.
47. Gentile, M.T., Vecchione, C., Marino, G., Aretini, A., Di Pardo, A., Antenucci, G., Maffei, A., Cifelli, G., Iorio, L., Landolfi, A., Frati, G. and Lembo, G. (2008) Resistin impairs insulin-evoked vasodilation. Diabetes 57, 577-583.
48. George, J., Patal, S., Wexler, D., Sharabi, Y., Peleg, E., Kamari, Y., Grossman, E., Sheps, D., Keren, G. and Roth, A. (2006) Circulating adiponectin concentrations in patients with congestive heart failure. Heart 92, 1420-1424.
49. Gómez-Ambrosi, J. and Frühbeck, G. (2001) Do resistin and resistin-like molecules also link obesity to inflammatory diseases?. Annals of Internal Medicine 135, 306-307.
50. Gómez-Ambrosi, J. and Frühbeck, G. (2005) Evidence for the involvement of resistin in inflammation and cardiovascular disease. Current Diabetes Reviews 1, 227-234.
51. Gómez-Ambrosi, J., Salvador, J., Páramo, J., Orbe, J., Irala, J. de, Díez-Caballero, A., Gil, M., Cienfuegos, J. and Frühbeck, G. (2002) Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clinical Biochemistry 35, 315-320.
52. Gómez-Ambrosi, J., Salvador, J., Rotellar, F., Silva, C., Catalán, V., Rodríguez, A., Gil, M.J. and Frühbeck, G. (2006) Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obesity Surgery 16, 262-269.
53. Gómez-Ambrosi, J., Catalán, V., Ramírez, B., Rodríguez, A., Colina, I., Silva, C., Rotellar, F., Mugueta, C., Gil, M.J., Cienfuegos, J.A., Salvador, J. and Frühbeck, G. (2007) Plasma osteopontin levels and expression in adipose tissue are increased in obesity. Journal of Clinical Endocrinology and Metabolism 92, 3719-3727.
54. Gómez-Ambrosi, J., Rodríguez, A., Catalán, V., Ramírez, B., Silva, C., Rotellar, F., Gil, M.J., Salvador, J. and Frühbeck, G. (2008) Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass. Clinical Endocrinology 69, 208-215.
55. Goralski, K.B., McCarthy, T.C., Hanniman, E.A., Zabel, B.A., Butcher, E.C., Parlee, S.D., Muruganandan, S. and Sinal, C.J. (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. Journal of Biological Chemistry 282, 28175-28188.
56. Graf, K., Do, Y.S., Ashizawa, N., Meehan, W.P., Giachelli, C.M., Marboe, C.C., Fleck, E. and Hsueh, W.A. (1997) Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 96, 3063-3071.
57. Graham, T., Yang, Q., Bluher, M., Hammarstedt, A., Ciaraldi, T., Henry, R., Wason, C., Oberbach, A., Jansson, P., Smith, U. and Kahn, B. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New England Journal of Medicine 354, 2552-2563.
58. Gualillo, O., González-Juanatey, J.R. and Lago, F. (2007) The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends in Cardiovascular Medicine 17, 275-283.
59. Haider, D.G., Pleiner, J., Francesconi, M., Wiesinger, G.F., Muller, M. and Wolzt, M. (2006a) Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 91, 4702-4704.
60. Haider, D.G., Schindler, K., Schaller, G., Prager, G., Wolzt, M. and Ludvik, B. (2006b) Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. Journal of Clinical Endocrinology and Metabolism 91, 1578-1581.
61. Hall, J. (1997) Mechanisms of abnormal renal sodium handling in obesity hypertension. American Journal of Hypertension 10, 49S-55S.
62. Haynes, W., Morgan, D., Walsh, S., Mark, A. and Sivitz, W. (1997) Receptor-mediated regional sympathetic nerve activation by leptin. The Journal of Clinical Investigation 100, 270-278.
63. Heilbronn, L., Rood, J., Janderova, L., Albu, J., Kelley, D., Ravussin, E. and Smith, S. (2004) Relationship between serum resistin concentrations and insulin resistance in non-obese, obese, and obese diabetic subjects. Journal of Clinical Endocrinology and Metabolism 89, 1844-1848.
64. Herbert, A., Liu, C., Karamohamed, S., Schiller, J., Liu, J., Yang, Q., Wilson, P., Cupples, L. and Meigs, J. (2005) The -174 IL-6 GG genotype is associated with a reduced risk of type 2 diabetes mellitus in a family sample from the National Heart, Lung and Blood Institute's Framingham Heart Study. Diabetologia 48, 1492-1495.
65. Herbert, A., Liu, C., Karamohamed, S., Liu, J., Manning, A., Fox, C., Meigs, J. and Cupples, L. (2006) BMI modifies associations of IL-6 genotypes with insulin resistance: the Framingham Study. Obesity 14, 1454-1461.
66. Hernández, R., Teruel, T., Alvaro, C. de and Lorenzo, M. (2004) Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-alpha induction of p38 and p42/p44 mitogen-activated protein kinases. Diabetologia 47, 1615-1624.
67. Hosoda, H., Kojima, M., Matsuo, H. and Kangawa, K. (2000) Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochemical and Biophysical Research Communications 279, 909-913.
68. Hotamisligil, G., Murray, D., Choy, L. and Spiegelman, B. (1994) Tumor necrosis factor alpha inhibits signaling from the insulin receptor. The Proceedings of the National Academy of Science of the United States of America 91, 4854-4858.
69. Hotamisligil, G., Arner, P., Caro, J., Atkinson, R. and Spiegelman, B. (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. The Journal of Clinical Investigation 95, 2409-2415.
70. Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S., Sakai, N., Nakajima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Hanafusa, T. and Matsuzawa, Y. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 20, 1595-1599.
71. Hotta, K., Funahashi, T., Bodkin, N., Ortmeyer, H., Arita, Y., Hansen, B. and Matsusawa, Y. (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50, 1126-1133.
72. Iglesias, M.J., Pineiro, R., Blanco, M., Gallego, R., Dieguez, C., Gualillo, O., Gonzalez-Juanatey, J.R. and Lago, F. (2004) Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovascular Research 62, 481-488.
73. Iqbal, N., Seshadri, P., Stern, L., Loh, J., Kundu, S., Jafar, T. and Samaha, F.F. (2005) Serum resistin is not associated with obesity or insulin resistance in humans. The European Review for Medical and Pharmacological Sciences 9, 161-165.
74. Ishida, J., Hashimoto, T., Hashimoto, Y., Nishiwaki, S., Iguchi, T., Harada, S., Sugaya, T., Matsuzaki, H., Yamamoto, R., Shiota, N., Okunishi, H., Kihara, M., Umemura, S., Sugiyama, F., Yagami, K., Kasuya, Y., Mochizuki, N. and Fukamizu, A. (2004) Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. Journal of Biological Chemistry 279, 26274-26279.
75. Ishikawa, Y., Akasaka, Y., Ishii, T., Yoda-Murakami, M., Choi-Miura, N.H., Tomita, M., Ito, K., Zhang, L., Akishima, Y., Ishihara, M., Muramatsu, M. and Taniyama, M. (2003) Changes in the distribution pattern of gelatin-binding protein of 28 kDa (adiponectin) in myocardial remodelling after ischaemic injury. Histopathology 42, 43-52.
76. Isoda, K., Kamezawa, Y., Ayaori, M., Kusuhara, M., Tada, N. and Ohsuzu, F. (2003) Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation 107, 679-681.
77. Jackson, E. and Li, P. (1997) Human leptin has natriuretic activity in the rat. American Journal of Physiology 272, F333-F338.
78. Janke, J., Engeli, S., Boschmann, M., Adams, F., Bohnke, J., Luft, F.C., Sharma, A.M. and Jordan, J. (2006) Retinol-binding protein 4 in human obesity. Diabetes 55, 2805-2810.
79. Jensen, L.E. and Whitehead, A.S. (1998) Regulation of serum amyloid A protein expression during the acute-phase response. Biochemical Journal 334 (Pt 3), 489-503.
80. Jousilahti, P., Salomaa, V., Rasi, V., Vahtera, E. and Palosuo, T. (2001) The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease -baseline findings of the PAIS project. Atherosclerosis 156, 451-456.
81. Jung, H.S., Park, K.H., Cho, Y.M., Chung, S.S., Cho, H.J., Cho, S.Y., Kim, S.J., Kim, S.Y., Lee, H.K. and Park, K.S. (2006) Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovascular Research 69, 76-85.
82. Karlsson, C., Lindell, K., Ottosson, M., Sjostrom, L., Carlsson, B. and Carlsson, L.M. (1998) Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. Journal of Clinical Endocrinology and Metabolism 83, 3925-3929.
83. Kim, S. and Moustaid-Moussa, N. (2000) Secretory, endocrine and autocrine/paracrine function of the adipocyte. Journal of Nutrition 130, 3110S-3115S.
84. Kimura, K., Tsuda, K., Baba, A., Kawabe, T., Boh-oka, S., Ibata, M., Moriwaki, C., Hano, T. and Nishio, I. (2000) Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochemical and Biophysical Research Communications 273, 745-749.
85. Kistorp, C., Faber, J., Galatius, S., Gustafsson, F., Frystyk, J., Flyvbjerg, A. and Hildebrandt, P. (2005) Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112, 1756-1762.
86. Klein, J., Perwitz, N., Kraus, D. and Fasshauer, M. (2006) Adipose tissue as source and target for novel therapies. Trends in Endocrinology and Metabolism 17, 26-32.
87. Kleinz, M.J. and Baxter, G.F. (2008) Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regulatory Peptides 146, 271-277.
88. Kleinz, M., Maguire, J., Skepper, J. and Davenport, A. (2006) Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovascular Research 69, 227-235.
89. Knerr, I., Herzog, D., Rauh, M., Rascher, W. and Horbach, T. (2006) Leptin and ghrelin expression in adipose tissues and serum levels in gastric banding patients. The European Journal of Clinical Investigation 36, 389-394.
90. Knudson, J.D., Dincer, U.D., Dick, G.M., Shibata, H., Akahane, R., Saito, M. and Tune, J.D. (2005) Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction. American Journal of Physiology -Heart and Circulatory Physiology 289, H1038-1046.
91. Koistinen, H., Vidal, H., Karonen, S., Dusserre, E., Vallier, P., Koivisto, V. and Ebeling, P. (2001) Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in non-diabetic and type 2 diabetic men. Arteriosclerosis, Thrombosis, and Vascular Biology 21, 1034-1039.
92. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H. and Kangawa, K. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660.
93. Kopelman, P.G. (2000) Obesity as a medical problem. Nature 404, 635-643.
94. Krauss, R., Winston, M., Fletcher, B. and Grundy, S. (1998) Obesity: impact on cardiovascular disease. Circulation 98, 1472-1476.
95. Krzyzanowska, K., Krugluger, W., Mittermayer, F., Rahman, R., Haider, D., Shnawa, N. and Schernthaner, G. (2006) Increased visfatin concentrations in women with gestational diabetes mellitus. Clinical Science 110, 605-609.
96. Kubota, N., Terauchi, Y., Yamauchi, T., Kubota, T., Moroi, M., Matsui, J., Eto, K., Yamashita, T., Kamon, J., Satoh, H., Yano, W., Froguel, P., Nagai, R., Kimura, S., Kadowaki, T. and Noda, T. (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. Journal of Biological Chemistry 277, 25863-25866.
97. Kuk, J.L., Katzmarzyk, P.T., Nichaman, M.Z., Church, T.S., Blair, S.N. and Ross, R. (2006) Visceral fat is an independent predictor of all-cause mortality in men. Obesity 14, 336-341.
98. Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., Nakamura, T., Funahashi, T. and Matsuzawa, Y. (2003) Association of hypoadiponectinemia with coronary artery disease in men. Arteriosclerosis, Thrombosis, and Vascular Biology 23, 85-89.
99. Kunnari, A., Ukkola, O., Paivansalo, M. and Kesaniemi, Y.A. (2006) High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. Journal of Clinical Endocrinology and Metabolism 91, 2755-2760.
100. Kusminski, C.M., McTernan, P.G. and Kumar, S. (2005) Role of resistin in obesity, insulin resistance and Type II diabetes. Clinical Science 109, 243-256.
101. Lee, D.K., George, S.R. and O'Dowd, B.F. (2006) Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends in Pharmaceutical Sciences 27, 190-194.
102. Lee, J., Chan, J., Yiannakouris, N., Kontogianni, M., Estrada, E., Seip, R., Orlova, C. and Mantzoros, C. (2003) Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. Journal of Clinical Endocrinology and Metabolism 88, 4848-4856.
103. Lehrke, M., Reilly, M., Millington, S., Iqbal, N., Rader, D. and Lazar, M. (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Medicine 1, e45.
104. Lembo, G., Vecchione, C., Fratta, L., Marino, G., Trimarco, V., d'Amati, G. and Trimarco, B. (2000) Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 49, 293-297.
105. Lenga, Y., Koh, A., Perera, A.S., McCulloch, C.A., Sodek, J. and Zohar, R. (2008) Osteopontin expression is required for myofibroblast differentiation. Circulation Research 102, 319-327.
106. Li, R., Wang, W.Q., Zhang, H., Yang, X., Fan, Q., Christopher, T.A., Lopez, B.L., Tao, L., Goldstein, B.J., Gao, F. and Ma, X.L. (2007) Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. American Journal of Physiology -Endocrinology and Metabolism 293, E1703-1708.
107. Li, W., Gavrila, D., Liu, X., Wang, L., Gunnlaugsson, S., Stoll, L., McCormick, M., Sigmund, C., Tang, C. and Weintraub, N. (2004) Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 109, 2221-2226.
108. Lin, Y., Matsumura, K., Fukuhara, M., Kagiyama, S., Fujii, K. and Iida, M. (2004) Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension 43, 977-982.
109. Lubos, E., Messow, C.M., Schnabel, R., Rupprecht, H.J., Espinola-Klein, C., Bickel, C., Peetz, D., Post, F., Lackner, K.J., Tiret, L., Munzel, T. and Blankenberg, S. (2007) Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis 193, 121-128.
110. McTernan, P., Fisher, F., Valsamakis, G., Chetty, R., Harte, A., McTernan, C., Clark, P., Smith, S., Barnett, A. and Kumar, S. (2003) Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. Journal of Clinical Endocrinology and Metabolism 88, 6098-6106.
111. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y. and Matsubara, K. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochemical and Biophysical Research Communications 221, 286-289.
112. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., Komuro, R., Ouchi, N., Kihara, S., Tochino, Y., Okutomi, K., Horie, M., Takeda, S., Aoyama, T., Funahashi, T. and Matsuzawa, Y. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ ACRP30. Nature Medicine 8, 731-737.
113. Malle, E. and De Beer, F.C. (1996) Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. European Journal of Clinical Investigation 26, 427-435.
114. Marsh, A., Fontes, M., Killinger, S., Pawlak, D., Polson, J. and Dampney, R. (2003) Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension 42, 488-493.
115. Matsuda, M., Shimomura, I., Sata, M., Arita, Y., Nishida, M., Maeda, N., Kumada, M., Okamoto, Y., Nagaretani, H., Nishizawa, H., Kishida, K., Komuro, R., Ouchi, N., Kihara, S., Nagai, R., Funahashi, T. and Matsuzawa, Y. (2002) Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. Journal of Biological Chemistry 277, 37487-37491.
116. Matsumura, K., Abe, I., Tsuchihashi, T. and Fujishima, M. (2000) Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. American Journal of Physiology -Regulatory, Integrative and Comparative Physiology 278, R1314-1320.
117. Mertens, I., Verrijken, A., Michiels, J., van der Planken, M., Ruige, J. and van Gaal, L. (2006) Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. International Journal of Obesity 30, 1308-1314.
118. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D.R., Miles, J.M., Yudkin, J.S., Klein, S. and Coppack, S.W. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. Journal of Clinical Endocrinology and Metabolism 82, 4196-4200.
119. Moller, D. (2000) Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends in Endocrinology and Metabolism 11, 212-217.
120. Morrow, D.A., Rifai, N., Antman, E.M., Weiner, D.L., McCabe, C.H., Cannon, C.P. and Braunwald, E. (2000) Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. Journal of the American College of Cardiology 35, 358-362.
121. Muscari, A., Bozzoli, C., Puddu, G., Sangiorgi, Z., Dormi, A., Rovinetti, C., Descovich, G. and Puddu, P. (1995) Association of serum C3 levels with the risk of myocardial infarction. American Journal of Medicine 98, 357-364.
122. Nagaya, N., Kojima, M., Uematsu, M., Yamagishi, M., Hosoda, H., Oya, H., Hayashi, Y. and Kangawa, K. (2001a) Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. American Journal of Physiology -Regulatory, Integrative and Comparative Physiology 280, R1483-1487.
123. Nagaya, N., Miyatake, K., Uematsu, M., Oya, H., Shimizu, W., Hosoda, H., Kojima, M., Nakanishi, N., Mori, H. and Kangawa, K. (2001b) Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. Journal of Clinical Endocrinology and Metabolism 86, 5854-5859.
124. Naldini, A., Leali, D., Pucci, A., Morena, E., Carraro, F., Nico, B., Ribatti, D. and Presta, M. (2006) Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontinactivated human monocytes. The Journal of Immunology 177, 4267-4270.
125. Narkiewicz, K., Somers, V., Mos, L., Kato, M., Accurso, V. and Palatini, P. (1999) An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. Journal of Hypertension 17, 245-249.
126. Natal, C., Fortuno, M.A., Restituto, P., Bazan, A., Colina, I., Diez, J. and Varo, N. (2008) Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. American Journal of Physiology -Endocrinology and Metabolism 294, E52-60.
127. Nickola, M.W., Wold, L.E., Colligan, P.B., Wang, G.J., Samson, W.K. and Ren, J. (2000) Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension 36, 501-505.
128. Norata, G.D., Ongari, M., Garlaschelli, K., Raselli, S., Grigore, L. and Catapano, A.L. (2007) Plasma resistin levels correlate with determinants of the metabolic syndrome. European Journal of Endocrinology 156, 279-284.
129. Ohashi, K., Kihara, S., Ouchi, N., Kumada, M., Fujita, K., Hiuge, A., Hibuse, T., Ryo, M., Nishizawa, H., Maeda, N., Maeda, K., Shibata, R., Walsh, K., Funahashi, T. and Shimomura, I. (2006) Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47, 1108-1116.
130. Okumura, H., Nagaya, N., Enomoto, M., Nakagawa, E., Oya, H. and Kangawa, K. (2002) Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. Journal of Cardiovascular Pharmacology 39, 779-783.
131. Oral, H., Dorn, G. and Mann, D. (1997) Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. Journal of Biological Chemistry 272, 4836-4842.
132. Otero, M., Lago, R., Lago, F., Casanueva, F.F., Diéguez, C., Gómez-Reino, J.J. and Gualillo, O. (2005) Leptin, from fat to inflammation: old questions and new insights. FEBS Letters 579, 295-301.
133. Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., Yamashita, S., Funahashi, T. and Matsuzawa, Y. (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100, 2473-2476.
134. Ouchi, N., Kihara, S., Funahashi, T., Nakamura, T., Nishida, M., Kumada, M., Okamoto, Y., Ohashi, K., Nagaretani, H., Kishida, K., Nishizawa, H., Maeda, N., Kobayashi, H., Hiraoka, H. and Matsuzawa, Y. (2003a) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107, 671-674.
135. Ouchi, N., Ohishi, M., Kihara, S., Funahashi, T., Nakamura, T., Nagaretani, H., Kumada, M., Ohashi, K., Okamoto, Y., Nishizawa, H., Kishida, K., Maeda, N., Nagasawa, A., Kobayashi, H., Hiraoka, H., Komai, N., Kaibe, M., Rakugi, H., Ogihara, T. and Matsuzawa, Y. (2003b) Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42, 231-234.
136. Ouedraogo, R., Gong, Y., Berzins, B., Wu, X., Mahadev, K., Hough, K., Chan, L., Goldstein, B.J. and Scalia, R. (2007) Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. The Journal of Clinical Investigation 117, 1718-1726.
137. Pagano, C., Pilon, C., Olivieri, M., Mason, P., Fabris, R., Serra, R., Milan, G., Rossato, M., Federspil, G. and Vettor, R. (2006) Reduced plasma visfatin/pre-B cell colonyenhancing factor in obesity is not related to insulin resistance in humans. Journal of Clinical Endocrinology and Metabolism 91, 3165-3170.
138. Pearson, T.A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O. 3rd, Criqui, M., Fadl, Y.Y., Fortmann, S.P., Hong, Y., Myers, G.L., Rifai, N., Smith, S.C. Jr, Taubert, K., Tracy, R.P. and Vinicor, F. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499-511.
139. Pepys, M.B. and Hirschfield, G.M. (2003) C-reactive protein: a critical update. The Journal of Clinical Investigation 111, 1805-1812.
140. Piñeiro, R., Iglesias, M.J., Gallego, R., Raghay, K., Eiras, S., Rubio, J., Diéguez, C., Gualillo, O., González-Juanatey, J.R. and Lago, F. (2005) Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Letters 579, 5163-5169.
141. Pischon, T., Girman, C.J., Hotamisligil, G.S., Rifai, N., Hu, F.B. and Rimm, E.B. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. The Journal of the American Medical Association 291, 1730-1737.
142. Poykko, S., Ukkola, O., Kauma, H., Kellokoski, E., Horkko, S. and Kesaniemi, Y. (2005) The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes. Diabetologia 48, 309-316.
143. Purdham, D.M., Zou, M.X., Rajapurohitam, V. and Karmazyn, M. (2004) Rat heart is a site of leptin production and action. American Journal of Physiology -Heart and Circulatory Physiology 287, H2877-2884.
144. Quadro, L., Blaner, W.S., Salchow, D.J., Vogel, S., Piantedosi, R., Gouras, P., Freeman, S., Cosma, M.P., Colantuoni, V. and Gottesman, M.E. (1999) Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. The EMBO Journal 18, 4633-4644.
145. Rahmouni, K., Morgan, D.A., Morgan, G.M., Mark, A.L. and Haynes, W.G. (2005) Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54, 2012-2018.
146. Rajapurohitam, V., Javadov, S., Purdham, D.M., Kirshenbaum, L.A. and Karmazyn, M. (2006) An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. The Journal of Molecular and Cellular Cardiology 41, 265-274.
147. Rangaswami, H., Bulbule, A. and Kundu, G.C. (2006) Osteopontin: role in cell signaling and cancer progression. Trends in Cell Biology 16, 79-87.
148. Reilly, M.P., Lehrke, M., Wolfe, M.L., Rohatgi, A., Lazar, M.A. and Rader, D.J. (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111, 932-939.
149. Ren, J. (2004) Leptin and hyperleptinemia -from friend to foe for cardiovascular function. Journal of Endocrinology 181, 1-10.
150. Rodríguez, A., Frühbeck, G., Gómez-Ambrosi, J., Catalán, V., Sáinz, N., Díez, J., Zalba, G. and Fortuño, A. (2006) The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats. Journal of Hypertension 24, 1589-1597.
151. Rodríguez, A., Catalán, V., Gómez-Ambrosi, J. and Frühbeck, G. (2007a) Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome?. Current Pharmaceutical Design 13, 2169-2175.
152. Rodríguez, A., Fortuño, A., Gómez-Ambrosi, J., Zalba, G., Díez, J. and Frühbeck, G. (2007b) The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology 148, 324-331.
153. Rothwell, S.E., Richards, A.M. and Pemberton, C.J. (2006) Resistin worsens cardiac ischaemia-reperfusion injury. Biochemical and Biophysical Research Communications 349, 400-407.
154. Sattar, N., Wannamethee, G., Sarwar, N., Tchernova, J., Cherry, L., Wallace, A., Danesh, J. and Whincup, P. (2006) Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 114, 623-629.
155. Savage, D., Sewter, C., Klenk, E., Segal, D., Vidal-Puig, A., Considine, R. and O'Rahilly, S. (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferatoractivated receptor-gamma action in humans. Diabetes 50, 2199-2202.
156. Schulze, P., Kratzsch, J., Linke, A., Schoene, N., Adams, V., Gielen, S., Erbs, S., Moebius-Winkler, S. and Schuler, G. (2003) Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. European Journal of Heart Failure 5, 33-40.
157. Schulze, M.B., Shai, I., Rimm, E.B., Li, T., Rifai, N. and Hu, F.B. (2005) Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 54, 534-539.
158. Sharma, A.M. (2006) The obese patient with diabetes mellitus: from research targets to treatment options. The American Journal of Medicine 119, S17-S23.
159. Shek, E., Brands, M. and Hall, J. (1998) Chronic leptin infusion increases arterial pressure. Hypertension 31, 409-414.
160. Shibata, R., Ouchi, N., Ito, M., Kihara, S., Shiojima, I., Pimentel, D.R., Kumada, M., Sato, K., Schiekofer, S., Ohashi, K., Funahashi, T., Colucci, W.S. and Walsh, K. (2004) Adiponectin-mediated modulation of hypertrophic signals in the heart. Nature Medicine 10, 1384-1389.
161. Shibata, R., Sato, K., Pimentel, D.R., Takemura, Y., Kihara, S., Ohashi, K., Funahashi, T., Ouchi, N. and Walsh, K. (2005) Adiponectin protects against myocardial ischemiareperfusion injury through AMPK-and COX-2-dependent mechanisms. Nature Medicine 11, 1096-1103.
162. Shibata, R., Izumiya, Y., Sato, K., Papanicolaou, K., Kihara, S., Colucci, W.S., Sam, F., Ouchi, N. and Walsh, K. (2007) Adiponectin protects against the development of systolic dysfunction following myocardial infarction. The Journal of Molecular and Cellular Cardiology 42, 1065-1074.
163. Shimabukuro, M., Higa, N., Asahi, T., Oshiro, Y., Takasu, N., Tagawa, T., Ueda, S., Shimomura, I., Funahashi, T. and Matsuzawa, Y. (2003) Hypoadiponectinemia is closely linked to endothelial dysfunction in man. Journal of Clinical Endocrinology and Metabolism 88, 3236-3240.
164. Shklyaev, S., Aslanidi, G., Tennant, M., Prima, V., Kohlbrenner, E., Kroutov, V., Campbell-Thompson, M., Crawford, J., Shek, E.W., Scarpace, P.J. and Zolotukhin, S. (2003) Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. The Proceedings of the National Academy of Science of the United States of America 100, 14217-14222.
165. Silha, J., Krsek, M., Skrha, J., Sucharda, P., Nyomba, B. and Murphy, L. (2003) Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. European Journal of Endocrinology 149, 331-335.
166. Sjöholm, K., Palming, J., Olofsson, L., Gummesson, A., Svensson, P., Lystig, T., Jennische, E., Brandberg, J., Torgerson, J., Carlsson, B. and Carlsson, L. (2005) A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. Journal of Clinical Endocrinology and Metabolism 90, 2233-2239.
167. Smith, C.C., Mocanu, M.M., Davidson, S.M., Wynne, A.M., Simpkin, J.C. and Yellon, D.M. (2006) Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. British Journal of Pharmacology 149, 5-13.
168. Smith, S.C. Jr, Blair, S.N., Bonow, R.O., Brass, L.M., Cerqueira, M.D., Dracup, K., Fuster, V., Gotto, A., Grundy, S.M., Miller, N.H., Jacobs, A., Jones, D., Krauss, R.M., Mosca, L., Ockene, I., Pasternak, R.C., Pearson, T., Pfeffer, M.A., Starke, R.D. and Taubert, K.A. (2001) AHA/ACC Guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Journal of the American College of Cardiology 38, 1581-1583.
169. Sobel, B. (1999) Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox. Circulation 99, 2496-2498.
170. Söderberg, S., Stegmayr, B., Ahlbeck-Glader, C., Slunga-Birgander, L., Ahren, B. and Olsson, T. (2003) High leptin levels are associated with stroke. Cerebrovascular Diseases 15, 63-69.
171. Soeki, T., Kishimoto, I., Schwenke, D.O., Tokudome, T., Horio, T., Yoshida, M., Hosoda, H. and Kangawa, K. (2008) Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. American Journal of Physiology -Heart and Circulatory Physiology 294, H426-432.
172. Spranger, J., Kroke, A., Mohlig, M., Bergmann, M., Ristow, M., Boeing, H. and Pfeiffer, A. (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361, 226-228.
173. Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., Patel, H.R., Ahima, R.S. and Lazar, M.A. (2001) The hormone resistin links obesity to diabetes. Nature 409, 307-312.
174. Sun, M., Dawood, F., Wen, W., Chen, M., Dixon, I., Kirshenbaum, L. and Liu, P. (2004) Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 110, 3221-3228.
175. Szokodi, I., Tavi, P., Foldes, G., Voutilainen-Myllyla, S., Ilves, M., Tokola, H., Pikkarainen, S., Piuhola, J., Rysa, J., Toth, M. and Ruskoaho, H. (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circulation Research 91, 434-440.
176. Takeishi, Y., Niizeki, T., Arimoto, T., Nozaki, N., Hirono, O., Nitobe, J., Watanabe, T., Takabatake, N. and Kubota, I. (2007) Serum resistin is associated with high risk in patients with congestive heart failure -a novel link between metabolic signals and heart failure. Circulation Journal 71, 460-464.
177. Tamori, Y., Sakaue, H. and Kasuga, M. (2006) RBP4, an unexpected adipokine. Nature Medicine 12, 30-31.
178. Tatemoto, K., Hosoya, M., Habata, Y., Fujii, R., Kakegawa, T., Zou, M.X., Kawamata, Y., Fukusumi, S., Hinuma, S., Kitada, C., Kurokawa, T., Onda, H. and Fujino, M. (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochemical and Biophysical Research Communications 251, 471-476.
179. Tatemoto, K., Takayama, K., Zou, M.X., Kumaki, I., Zhang, W., Kumano, K. and Fujimiya, M. (2001) The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regulatory Peptides 99, 87-92.
180. Tesauro, M., Schinzari, F., Iantorno, M., Rizza, S., Melina, D., Lauro, D. and Cardillo, C. (2005) Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 112, 2986-2992.
181. Tilg, H. and Moschen, A.R. (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 6, 772-783.
182. Tschöp, M., Smiley, D.L. and Heiman, M.L. (2000) Ghrelin induces adiposity in rodents. Nature 407, 908-913.
183. Tschöp, M., Weyer, C., Tataranni, P.A., Devanarayan, V., Ravussin, E. and Heiman, M.L. (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50, 707-709.
184. Tsubota, Y., Owada-Makabe, K., Yukawa, K. and Maeda, M. (2005) Hypotensive effect of des-acyl ghrelin at nucleus tractus solitarii of rat. Neuroreport 16, 163-166.
185. Uhlar, C.M. and Whitehead, A.S. (1999) Serum amyloid A, the major vertebrate acutephase reactant. European Journal of Biochemistry 265, 501-523.
186. Verma, S., Li, S.H., Wang, C.H., Fedak, P.W., Li, R.K., Weisel, R.D. and Mickle, D.A. (2003) Resistin promotes endothelial cell activation: further evidence of adipokineendothelial interaction. Circulation 108, 736-740.
187. Villarreal, D., Reams, G., Freeman, R. and Taraben, A. (1998) Renal effects of leptin in normotensive, hypertensive, and obese rats. American Journal of Physiology 275, R2056-R2060.
188. Villarreal, D., Reams, G., Samar, H., Spear, R. and Freeman, R. (2004) Effects of chronic nitric oxide inhibition on the renal excretory response to leptin. Obesity Research 12, 1006-1010.
189. Waki, H., Yamauchi, T., Kamon, J., Ito, Y., Uchida, S., Kita, S., Hara, K., Hada, Y., Vasseur, F., Froguel, P., Kimura, S., Nagai, R. and Kadowaki, T. (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. Journal of Biological Chemistry 278, 40352-40363.
190. Wassmann, S., Stumpf, M., Strehlow, K., Schmid, A., Schieffer, B., Bohm, M. and Nickenig, G. (2004) Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circulation Research 94, 534-541.
191. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L. and Ferrante, A.W. Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation 112, 1796-1808.
192. Wilson, P., D'Agostino, R., Sullivan, L., Parise, H. and Kannel, W. (2002) Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Archives of Internal Medicine 162, 1867-1872.
193. Wisse, B.E. (2004) The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. Journal of the American Society of Nephrology 15, 2792-2800.
194. Wold, L., Relling, D., Duan, J., Norby, F. and Ren, J. (2002) Abrogated leptin-induced cardiac contractile response in ventricular myocytes under spontaneous hypertension: role of Jak/STAT pathway. Hypertension 39, 69-74.
195. Wolk, R., Berger, P., Lennon, R.J., Brilakis, E.S., Davison, D.E. and Somers, V.K. (2007) Association between plasma adiponectin levels and unstable coronary syndromes. European Heart Journal 28, 292-298.
196. Wortley, K.E., Anderson, K.D., Garcia, K., Murray, J.D., Malinova, L., Liu, R., Moncrieffe, M., Thabet, K., Cox, H.J., Yancopoulos, G.D., Wiegand, S.J. and Sleeman, M.W. (2004) Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proceedings of the National Academy of Sciences of the United States of America 101, 8227-8232.
197. Wren, A.M., Small, C.J., Ward, H.L., Murphy, K.G., Dakin, C.L., Taheri, S., Kennedy, A.R., Roberts, G.H., Morgan, D.G., Ghatei, M.A. and Bloom, S.R. (2000) The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325-4328.
198. Wren, A.M., Small, C.J., Abbott, C.R., Dhillo, W.S., Seal, L.J., Cohen, M.A., Batterham, R.L., Taheri, S., Stanley, S.A., Ghatei, M.A. and Bloom, S.R. (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes 50, 2540-2547.
199. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N.H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R. and Kadowaki, T. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769.
200. Yang, Q., Graham, T., Mody, N., Preitner, F., Peroni, O., Zabolotny, J., Kotani, K., Quadro, L. and Kahn, B. (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436, 356-362.
201. Yang, R., Lee, M., Hu, H., Pollin, T., Ryan, A., Nicklas, B., Snitker, S., Horenstein, R., Hull, K., Goldberg, N., Goldberg, A., Shuldiner, A., Fried, S. and Gong, D. (2006) Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Medicine 3, e287.
202. Yang, R.Z., Huang, Q., Xu, A., McLenithan, J.C., Eisen, J.A., Shuldiner, A.R., Alkan, S. and Gong, D.W. (2003) Comparative studies of resistin expression and phylogenomics in human and mouse. Biochemical and Biophysical Research Communications 310, 927-935.
203. Yaspelkis, B., Davis, J., Saberi, M., Smith, T., Jazayeri, R., Singh, M., Fernández, V., Trevino, B., Chinookoswong, N., Wang, J., Shi, Z. and Levin, N. (2001) Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulinresistant rats. American Journal of Physiology -Endocrinology and Metabolism 280, E130-E142.
204. Yaturu, S., Daberry, R., Rains, J. and Jain, S. (2006) Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes. Cytokine 34, 219-223.
205. Yildiz, B., Suchard, M., Wong, M., McCann, S. and Licinio, J. (2004) Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proceedings of the National Academy of Sciences of the United States of America 101, 10434-10439.
206. Youn, B., Yu, K., Park, H., Lee, N., Min, S., Youn, M., Cho, Y., Park, Y., Kim, S., Lee, H. and Park, K. (2004) Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 89, 150-156.
207. Yusuf, S., Hawken, S., Ounpuu, S., Bautista, L., Franzosi, M.G., Commerford, P., Lang, C.C., Rumboldt, Z., Onen, C.L., Lisheng, L., Tanomsup, S., Wangai, P. Jr, Razak, F., Sharma, A.M. and Anand, S.S. (2005) Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366, 1640-1649.
208. Zahradka, P. (2008) Novel role for osteopontin in cardiac fibrosis. Circulation Research 102, 270-272.
209. Zhao, A., Bornfeldt, K. and Beavo, J. (1998) Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. The Journal of Clinical Investigation 102, 869-873.
210. Zhao, A., Shinohara, M., Huang, D., Shimizu, M., Eldar-Finkelman, H., Krebs, E., Beavo, J. and Bornfeldt, K. (2000) Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. Journal of Biological Chemistry 275, 11348-11354.